SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-13-449823
Filing Date
2013-11-21
Accepted
2013-11-21 16:04:23
Documents
4
Period of Report
2013-11-19
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d633343d8k.htm 8-K 14833
2 EX-99.1 d633343dex991.htm EX-99.1 9545
3 GRAPHIC g6333431.jpg GRAPHIC 9855
4 GRAPHIC g6333432.jpg GRAPHIC 1798
  Complete submission text file 0001193125-13-449823.txt   42002
Mailing Address 615 ARAPEEN DRIVE SUITE 102 SALT LAKE CITY UT 84108
Business Address 615 ARAPEEN DRIVE SUITE 102 SALT LAKE CITY UT 84108 (801) 582-5400
Q Therapeutics, Inc. (Filer) CIK: 0001366541 (see all company filings)

IRS No.: 203708500 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-52062 | Film No.: 131235445
SIC: 2834 Pharmaceutical Preparations